Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

This study is ongoing, but not recruiting participants.

Sponsor:

ClinicalTrials.gov Identifier:

NCT00324805

First Posted: May 11, 2006

Last Update Posted: July 26, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Collaborators:

Cancer and Leukemia Group B

NCIC Clinical Trials Group

North Central Cancer Treatment Group

Southwest Oncology Group

Information provided by (Responsible Party):

National Cancer Institute (NCI)

Study Status:	This study is ongoing, but not recruiting participants.
Study Completion Date:	No date given
Estimated Primary Completion Date:	January 1, 2018 (Final data collection date for primary outcome measure)

Study Status:

This study is ongoing, but not recruiting participants.

Study Completion Date:

No date given

Estimated Primary Completion Date:

January 1, 2018 (Final data collection date for primary outcome measure)